Antibodies against the C-terminus of apolipoprotein A-1 as predictors of death in the general population but not as therapeutic targets actionable through cognate peptides immunomodulation. (December 2020) - Vuilleumier, N.; Antiochos, P.; Pagano, S.; Marques-Vidal, P.; Virzi, J.; Satta, N.; Hartley, O.; Brandt, K.J.; Burger, F.; Montecucco, F.; Waeber, G.; Mach, F.